Early studies have demonstrated that the overexpression of Abeta in human skeletal muscle fibers and transgenic mice could induce GSK3β activation and the enhanced phosphorylation of TAU, leading to inclusion body myositis-like pathological outcomes, including both inclusion bodies and inflammatory infiltrates in mice [99,100]. This evidence concerns the gene APP and inclusion body myositis.